Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Among patients with stable atherosclerosis, low-dose methotrexate did not reduce levels of interleukin-1β, interleukin-6, or C-reactive protein and did not result in fewer cardi...
Publications
View AllInstitution Info
- Type
- healthcare
- Country
- US
- Publications
- 1
- Citations
- 1,220
External Links
Identifiers
- ROR
- https://ror.org/03qjk6p58